Annual Net Income
-$116.05 M
+$17.77 M+13.28%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual net profit is -$116.05 million, with the most recent change of +$17.77 million (+13.28%) on September 30, 2024.
- During the last 3 years, ENTA annual net income has fallen by -$37.05 million (-46.90%).
- ENTA annual net income is now -246.91% below its all-time high of $78.99 million, reached on September 30, 2015.
Performance
ENTA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$28.82 M
-$6.17 M-27.21%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly net profit is -$28.82 million, with the most recent change of -$6.17 million (-27.21%) on September 30, 2024.
- Over the past year, ENTA quarterly net income has dropped by -$716.00 thousand (-2.55%).
- ENTA quarterly net income is now -157.58% below its all-time high of $50.05 million, reached on June 30, 2014.
Performance
ENTA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$116.05 M
-$716.00 K-0.62%
September 30, 2024
Summary
- As of February 8, 2025, ENTA TTM net profit is -$116.05 million, with the most recent change of -$716.00 thousand (-0.62%) on September 30, 2024.
- Over the past year, ENTA TTM net income has increased by +$17.77 million (+13.28%).
- ENTA TTM net income is now -200.23% below its all-time high of $115.77 million, reached on March 31, 2015.
Performance
ENTA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ENTA Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.3% | -2.5% | +13.3% |
| 3 y3 years | -46.9% | -17.2% | -46.9% |
| 5 y5 years | -350.2% | -17.2% | -46.9% |
ENTA Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.9% | +13.3% | -27.2% | +26.2% | -15.1% | +16.1% |
| 5 y | 5-year | -350.2% | +13.3% | -314.4% | +26.2% | -443.2% | +16.1% |
| alltime | all time | -246.9% | +13.3% | -157.6% | +26.2% | -200.2% | +16.1% |
Enanta Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$116.05 M(-13.3%) | -$28.82 M(+27.2%) | -$116.05 M(+0.6%) |
| Jun 2024 | - | -$22.66 M(-27.3%) | -$115.33 M(-12.5%) |
| Mar 2024 | - | -$31.16 M(-6.7%) | -$131.74 M(-4.7%) |
| Dec 2023 | - | -$33.41 M(+18.9%) | -$138.24 M(+3.3%) |
| Sep 2023 | -$133.82 M(+9.9%) | -$28.11 M(-28.1%) | -$133.82 M(+1.3%) |
| Jun 2023 | - | -$39.06 M(+3.7%) | -$132.06 M(+5.9%) |
| Mar 2023 | - | -$37.66 M(+29.9%) | -$124.69 M(+3.4%) |
| Dec 2022 | - | -$28.99 M(+10.0%) | -$120.63 M(-0.9%) |
| Sep 2022 | -$121.75 M(+54.1%) | -$26.35 M(-16.9%) | -$121.75 M(+1.5%) |
| Jun 2022 | - | -$31.70 M(-5.6%) | -$120.01 M(+6.8%) |
| Mar 2022 | - | -$33.59 M(+11.5%) | -$112.33 M(+11.5%) |
| Dec 2021 | - | -$30.11 M(+22.4%) | -$100.78 M(+27.6%) |
| Sep 2021 | -$79.00 M(+118.4%) | -$24.60 M(+2.4%) | -$79.00 M(-5.7%) |
| Jun 2021 | - | -$24.02 M(+9.0%) | -$83.74 M(+13.2%) |
| Mar 2021 | - | -$22.05 M(+164.7%) | -$73.98 M(+27.7%) |
| Dec 2020 | - | -$8.33 M(-71.6%) | -$57.94 M(+60.2%) |
| Sep 2020 | -$36.17 M(-178.0%) | -$29.34 M(+105.7%) | -$36.17 M(-1629.9%) |
| Jun 2020 | - | -$14.27 M(+137.6%) | $2.36 M(-90.0%) |
| Mar 2020 | - | -$6.00 M(-144.7%) | $23.66 M(-30.0%) |
| Dec 2019 | - | $13.44 M(+46.3%) | $33.81 M(-27.1%) |
| Sep 2019 | $46.38 M(-35.5%) | $9.19 M(+30.6%) | $46.38 M(-28.2%) |
| Jun 2019 | - | $7.04 M(+69.7%) | $64.61 M(-17.0%) |
| Mar 2019 | - | $4.14 M(-84.1%) | $77.86 M(-9.7%) |
| Dec 2018 | - | $26.01 M(-5.1%) | $86.27 M(+19.9%) |
| Sep 2018 | $71.96 M | $27.42 M(+35.2%) | $71.96 M(-11.2%) |
| Jun 2018 | - | $20.29 M(+61.6%) | $81.04 M(+54.9%) |
| Mar 2018 | - | $12.55 M(+7.4%) | $52.33 M(+52.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $11.69 M(-68.0%) | $34.38 M(+94.1%) |
| Sep 2017 | $17.71 M(-18.3%) | $36.51 M(-533.3%) | $17.71 M(-186.0%) |
| Jun 2017 | - | -$8.43 M(+56.3%) | -$20.60 M(+55.5%) |
| Mar 2017 | - | -$5.39 M(+8.3%) | -$13.25 M(+39.4%) |
| Dec 2016 | - | -$4.98 M(+176.4%) | -$9.50 M(-143.9%) |
| Sep 2016 | $21.67 M(-72.6%) | -$1.80 M(+67.5%) | $21.67 M(-26.0%) |
| Jun 2016 | - | -$1.08 M(-34.6%) | $29.28 M(-10.7%) |
| Mar 2016 | - | -$1.65 M(-106.3%) | $32.77 M(-48.1%) |
| Dec 2015 | - | $26.19 M(+350.6%) | $63.17 M(-20.0%) |
| Sep 2015 | $78.99 M(+129.4%) | $5.81 M(+140.4%) | $78.99 M(+15.9%) |
| Jun 2015 | - | $2.42 M(-91.6%) | $68.14 M(-41.1%) |
| Mar 2015 | - | $28.75 M(-31.6%) | $115.77 M(+41.5%) |
| Dec 2014 | - | $42.01 M(-933.2%) | $81.82 M(+137.6%) |
| Sep 2014 | $34.44 M(+257.7%) | -$5.04 M(-110.1%) | $34.44 M(-1.7%) |
| Jun 2014 | - | $50.05 M(-1062.0%) | $35.04 M(-282.9%) |
| Mar 2014 | - | -$5.20 M(-3.1%) | -$19.15 M(+8.2%) |
| Dec 2013 | - | -$5.37 M(+20.9%) | -$17.70 M(-283.9%) |
| Sep 2013 | $9.63 M(-55.0%) | -$4.44 M(+7.4%) | $9.63 M(-3.9%) |
| Jun 2013 | - | -$4.14 M(+10.4%) | $10.02 M(-6.0%) |
| Mar 2013 | - | -$3.75 M(-117.1%) | $10.65 M(-77.1%) |
| Dec 2012 | - | $21.96 M(-641.9%) | $46.52 M(+117.4%) |
| Sep 2012 | $21.40 M(-8.2%) | -$4.05 M(+15.7%) | $21.40 M(-0.3%) |
| Jun 2012 | - | -$3.50 M(-110.9%) | $21.46 M(-14.0%) |
| Mar 2012 | - | $32.11 M(-1116.5%) | $24.96 M(-449.2%) |
| Dec 2011 | - | -$3.16 M(-20.8%) | -$7.15 M(+79.2%) |
| Sep 2011 | $23.31 M(+194.9%) | -$3.99 M | -$3.99 M |
| Sep 2010 | $7.90 M | - | - |
FAQ
- What is Enanta Pharmaceuticals annual net profit?
- What is the all time high annual net income for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual net income year-on-year change?
- What is Enanta Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly net income year-on-year change?
- What is Enanta Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM net income year-on-year change?
What is Enanta Pharmaceuticals annual net profit?
The current annual net income of ENTA is -$116.05 M
What is the all time high annual net income for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual net profit is $78.99 M
What is Enanta Pharmaceuticals annual net income year-on-year change?
Over the past year, ENTA annual net profit has changed by +$17.77 M (+13.28%)
What is Enanta Pharmaceuticals quarterly net profit?
The current quarterly net income of ENTA is -$28.82 M
What is the all time high quarterly net income for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly net profit is $50.05 M
What is Enanta Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ENTA quarterly net profit has changed by -$716.00 K (-2.55%)
What is Enanta Pharmaceuticals TTM net profit?
The current TTM net income of ENTA is -$116.05 M
What is the all time high TTM net income for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM net profit is $115.77 M
What is Enanta Pharmaceuticals TTM net income year-on-year change?
Over the past year, ENTA TTM net profit has changed by +$17.77 M (+13.28%)